Publications by authors named "Yu Ki Sim"
Article Synopsis
- Hepatocellular carcinoma (HCC) is a major cancer worldwide, with evolving treatments whose real-world application is not well understood; the INSIGHT study aimed to assess this in the Asia-Pacific region over a 7-year period following previous research.
- Data was gathered from 2,533 newly diagnosed HCC patients across 33 sites in 9 countries, highlighting hepatitis B as the primary risk factor in most areas, while Japan, Australia, and New Zealand showed more hepatitis C and diabetes cases among patients.
- The study found significant variations in first-line treatments among countries and disease stages, influencing survival rates, and emphasized that demographics, treatment costs, and therapy access could cause geographical differences
